THE IMPACT OF DIABETES AND HBA1C ON ELDER-PATIENTS AFTER PERCUTANEOUS CORONARY INTERVENTION: FROM SHINANO REGISTRY
2019; Elsevier BV; Volume: 73; Issue: 9 Linguagem: Inglês
10.1016/s0735-1097(19)30685-0
ISSN1558-3597
AutoresAyumu Nagae, Ken Nishikawa, Takashi Miura, Minami Taki, Masanori Kobayashi, M Kanai, Takashi Yanagisawa, Naoto Hashizume, Kyuhachi Otagiri, Kyoko Shoin, Yusuke Miyashita, Koki Fujimori, Daisuke Sunohara, Hisanori Yui, Shusaku Maruyama, Chié Nakamura, Daisuke Kashiwagi, Keisuke Senda, Takahiro Sakai, Tamon Katou, Tatsuya Saigusa, Soichiro Ebisawa, Ayako Okada, Hirohiko Motoki, Koichiro Kuwahara,
Tópico(s)Acute Myocardial Infarction Research
ResumoDiabetes is known to be one of the risks of arteriosclerosis. However, the therapeutic goal of HbA1c in diabetic elderly is still unclear, in particular, in secondary prevention after percutaneous coronary intervention (PCI). Between August 2012 and July 2013, a total of 1665 consecutive patients
Referência(s)